Ropark 0.25 MG (Ropinirole)
| Active Ingredient | Ropinirole |
|---|---|
| Manufacturers | Sun Pharmaceutical |
| Indications | Parkinson’s Disease |
| Strength | 0.25mg |
| Packaging | 10 Tablets in 1 Strip |
| Delivery Time | 6 To 15 days |
Ropark 0.25 mg is a dopamine agonist medication that contains Ropinirole, prescribed primarily for Parkinson’s disease and Restless Legs Syndrome (RLS). It works by activating dopamine receptors in the brain, mimicking the effects of natural dopamine — a key neurotransmitter involved in regulating movement and coordination. This action helps reduce symptoms such as tremors, muscle stiffness, and slowed movements associated with Parkinson’s, and relieves the uncomfortable urge to move the legs caused by RLS.
This low dose (0.25 mg) is often used at the start of treatment and may be gradually increased based on the patient’s response. Ropark should be taken as directed by a physician, with or without food. Sudden discontinuation should be avoided, as it may lead to withdrawal symptoms or worsening of disease symptoms. Regular use of Ropark can significantly improve motor function, sleep quality (in RLS), and overall quality of life in affected patients.








There are no reviews yet.